Emerging Treatment Approaches for HR+/HER2– Early-Stage Breast Cancer
December 4th 2024Panelists discuss how emerging treatment strategies, including the use of CDK4/6 inhibitors and personalized risk stratification, are transforming the management of high-risk HR+/HER2– early-stage breast cancer, emphasizing the importance of multidisciplinary care and patient-specific approaches.
Application of a Tissue-Free Epigenomic Assay to Improve MRD Detection in Previously Treated CRC
September 30th 2024Yoshiaki Nakamura, MD, PhD, discusses how a methylation-based circulating tumor DNA assay can enhance minimal residual disease detection and improve prognosis in patients with previously treated stage II-III colorectal cancer.
OncLive News Network: On Location at ASCO 2024
May 30th 2024OncLive® will be LIVE with OncLive® News Network: On Location at the 2024 ASCO Annual Meeting. Each day, we will broadcast a series of interviews with top thought leaders, to learn their thoughts and reactions to data presented across oncology during the conference.
Optimizing Outcomes in the Long-Term Management of Patients With AML
December 13th 2023Catherine Lai, MD, MPH, discusses strategies for optimizing outcomes in the long-term management of Acute Myeloid Leukemia (AML), particularly for patients in first remission without a transplant. She also shares perspectives on updates from the 65th ASH Annual Meeting.
Evolving Treatment Strategies in Chronic Lymphocytic Leukemia: Insights From ASH 2023
December 13th 2023Richard Furman, MD, and Chaitra S. Ujjani, MD, discuss the changing landscape of treatment strategies for patients with CLL, highlighting key updates presented at ASH 2023 and their potential implication on clinical practice.
Emerging Therapies in the Management of HR+, HER2- Metastatic Breast Cancer
December 13th 2023Experts provides an in-depth review of current and emerging options for the treatment of HR+, HER2- metastatic breast cancer, including discussions around overcoming endocrine resistance, sequencing combination therapies, and optimizing quality of life and outcomes.
Advances in Hepatocellular Carcinoma (HCC): Key Updates from AASLD 2023 and Beyond
December 12th 2023Anwaar Saeed, MD, and Amit Singal, MD, explore recent updates in the treatment of advanced hepatocellular carcinoma (HCC) presented at the 2023 AASLD: The Liver Meeting Congress and surrounding meetings.
OncLive News Network: On Location at ASH 2023
December 11th 2023Join us LIVE at this year's 2023 ASH Annual Meeting! OncLive® will broadcast a series of interviews with top thought leaders in hematologic malignancies, including chronic lymphocytic leukemia, acute lymphoblastic leukemia, myelodysplastic/myeloproliferative neoplasms, Hodgkin and non–Hodgkin lymphoma, multiple myeloma, and graft-vs-host-disease. The experts will share their insights and reactions to the pivotal data presented during the conference.